文献速递其他结缔组织病

COVID-19 与肌炎:患者面临的独特挑战

COVID-19 and myositis - unique challenges for patients.
PubMed 文献 · Rheumatology (Oxford) · 2021-01-01

该研究通过匿名电子问卷调查 608 例特发性炎性肌病(IIM)患者,评估 COVID-19 大流行对疾病控制、医疗连续性、药物获取及患者恐惧的影响。结果显示 32.1% 患者报告与疫情相关的健康问题,近四分之一面临药物获取困难,物理治疗中断占 35.2%,多数支持增加远程会诊。

要点

  • 32.1% 的 IIM 患者报告疫情相关健康问题,其中 52.3% 需增加药物、18% 因病相关并发症住院。
  • 52.7% 使用糖皮质激素和/或 53.8% 有心血管危险因素,属重症 COVID-19 高危人群。
  • 物理治疗中断占 35.2%,26.1% 联系专科医生困难,4.9% 无法联系。

核心结论

  • COVID-19 大流行对许多 IIM 患者的医疗连续性产生不利影响。
  • 临床照护的延迟和遗漏可能转化为未来更差的结局。

研究设计与样本

  • 匿名电子问卷调查,共纳入 608 例特发性炎性肌病患者(81.1% 女性,中位年龄 57 岁,s.d. 13.9)。

主要发现

  • 皮肌炎为最常见亚型(247 例,40.6%)。
  • 195 例(32.1%)报告与 COVID-19 大流行相关的健康问题,其中 102 例(52.3%)需增加药物,35 例(18%)因病相关并发症需住院。
  • 52.7% 使用糖皮质激素和/或 53.8% 有心血管危险因素。
  • 近四分之一患者面临药物获取障碍;物理治疗中断 214 例(35.2%)。
  • 159 例(26.1%)联系专科医生困难,30 例(4.9%)无法联系;69.6% 支持增加远程会诊。

临床怎么用

  • 对 IIM 患者需关注疫情下药物获取与物理治疗连续性,及时识别疾病活动并调整治疗。
  • 可推广远程会诊以维持医疗连续性,多数患者对此持支持态度。

局限性

  • 描述性研究设计,未报告对照或因果推断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The COVID-19 pandemic and the subsequent effects on healthcare systems is having a significant effect on the management of long-term autoimmune conditions. The aim of this study was to assess the problems faced by patients with idiopathic inflammatory myopathies (IIM). METHODS: An anonymized eSurvey was carried out with a focus on effects on disease control, continuity of medical care, drug procurance and prevalent fears in the patient population. RESULTS: Of the 608 participants (81.1% female, median (s.d.) age 57 (13.9) years), dermatomyositis was the most frequent subtype (247, 40.6%). Patients reported health-related problems attributable to the COVID-19 pandemic (n = 195, 32.1%); specifically 102 (52.3%) required increase in medicines, and 35 (18%) required hospitalization for disease-related complications. Over half (52.7%) of the surveyed patients were receiving glucocorticoids and/or had underlying cardiovascular risk factors (53.8%), placing them at higher risk for severe COVID-19. Almost one in four patients faced hurdles in procuring medicines. Physiotherapy, critical in the management of IIM, was disrupted in 214 (35.2%). One quarter (159, 26.1%) experienced difficulty in contacting their specialist, and 30 (4.9%) were unable to do so. Most (69.6%) were supportive of the increased use of remote consultations to maintain continuity of medical care during the pandemic. CONCLUSION: This large descriptive study suggests that the COVID-19 pandemic has incurred a detrimental effect on continuity of medical care for many patients with IIM. There is concern that delays and omissions in clinical care may potentially translate to poorer outcomes in the future.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Gupta L, Lilleker JB, Agarwal V, et al. COVID-19 and myositis - unique challenges for patients. Rheumatology (Oxford). 2021. PMID: 33175137. doi:10.1093/rheumatology/keaa610

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。